Share Price and Basic Stock Data
Last Updated: March 3, 2026, 1:54 pm
| PEG Ratio | 1.00 |
|---|
📊 Last updated
6d ago
Feb 26, 2026
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Bharat Seats Ltd operates in the automotive ancillary sector, focusing on manufacturing seating systems and interior components. The company reported a market capitalization of ₹1,229 Cr and a share price of ₹196. The revenue from operations has shown a positive trajectory, rising from ₹1,051 Cr in FY 2023 to ₹1,289 Cr in FY 2025, indicating a growth rate of approximately 22.7%. The trailing twelve-month (TTM) revenue stood at ₹1,585 Cr, showcasing the company’s ability to capture market demand effectively. Quarterly sales data reveals fluctuations, with a peak of ₹458.60 Cr in September 2025, although a notable decline occurred in December 2023 at ₹249.98 Cr. This seasonal variability in sales is indicative of the automotive industry’s cyclical nature, influenced by factors such as consumer demand and supply chain dynamics. Overall, Bharat Seats has demonstrated a robust revenue growth trend over the past few years, positioning itself favorably within the automotive ancillary market.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Bharat Seats Ltd | 1,136 Cr. | 181 | 240/62.5 | 27.5 | 32.9 | 0.61 % | 15.6 % | 18.0 % | 2.00 |
| Jay Bharat Maruti Ltd | 1,144 Cr. | 106 | 116/55.3 | 13.8 | 55.3 | 0.66 % | 7.87 % | 5.61 % | 2.00 |
| Precision Camshafts Ltd | 1,250 Cr. | 132 | 263/125 | 24.8 | 85.8 | 0.76 % | 6.19 % | 3.93 % | 10.0 |
| Automobile Corporation of Goa Ltd | 1,008 Cr. | 1,656 | 2,349/996 | 14.9 | 458 | 1.51 % | 20.2 % | 19.7 % | 10.0 |
| Munjal Auto Industries Ltd | 784 Cr. | 78.4 | 115/60.0 | 17.9 | 43.2 | 1.28 % | 11.8 % | 10.1 % | 2.00 |
| Industry Average | 5,615.90 Cr | 627.85 | 112.18 | 154.70 | 0.71% | 15.11% | 122.81% | 5.59 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 219.18 | 293.43 | 252.75 | 285.98 | 249.98 | 278.10 | 298.85 | 290.67 | 306.39 | 392.91 | 427.06 | 458.60 | 491.01 |
| Expenses | 209.03 | 278.77 | 240.66 | 269.04 | 235.33 | 260.98 | 282.34 | 273.01 | 287.81 | 370.20 | 405.35 | 435.95 | 465.88 |
| Operating Profit | 10.15 | 14.66 | 12.09 | 16.94 | 14.65 | 17.12 | 16.51 | 17.66 | 18.58 | 22.71 | 21.71 | 22.65 | 25.13 |
| OPM % | 4.63% | 5.00% | 4.78% | 5.92% | 5.86% | 6.16% | 5.52% | 6.08% | 6.06% | 5.78% | 5.08% | 4.94% | 5.12% |
| Other Income | 1.44 | 1.35 | 1.09 | 0.84 | 1.45 | 1.16 | 0.95 | 0.70 | 0.65 | 1.28 | 1.07 | 2.69 | -0.42 |
| Interest | 0.91 | 1.18 | 1.38 | 2.38 | 2.24 | 1.75 | 2.23 | 2.27 | 2.31 | 2.10 | 2.50 | 2.99 | 2.23 |
| Depreciation | 4.21 | 4.32 | 5.41 | 6.30 | 6.29 | 6.01 | 6.35 | 6.50 | 6.64 | 6.76 | 7.94 | 9.06 | 9.02 |
| Profit before tax | 6.47 | 10.51 | 6.39 | 9.10 | 7.57 | 10.52 | 8.88 | 9.59 | 10.28 | 15.13 | 12.34 | 13.29 | 13.46 |
| Tax % | 26.74% | 29.88% | 26.92% | 25.49% | 27.08% | 23.29% | 25.56% | 25.96% | 26.17% | 24.72% | 25.69% | 25.51% | 26.37% |
| Net Profit | 4.75 | 7.37 | 4.67 | 6.79 | 5.52 | 8.08 | 6.61 | 7.10 | 7.59 | 11.39 | 9.18 | 9.90 | 9.90 |
| EPS in Rs | 0.76 | 1.17 | 0.74 | 1.08 | 0.88 | 1.29 | 1.05 | 1.13 | 1.21 | 1.81 | 1.46 | 1.58 | 1.58 |
Last Updated: March 3, 2026, 11:48 am
Below is a detailed analysis of the quarterly data for Bharat Seats Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 491.01 Cr.. The value appears strong and on an upward trend. It has increased from 458.60 Cr. (Sep 2025) to 491.01 Cr., marking an increase of 32.41 Cr..
- For Expenses, as of Dec 2025, the value is 465.88 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 435.95 Cr. (Sep 2025) to 465.88 Cr., marking an increase of 29.93 Cr..
- For Operating Profit, as of Dec 2025, the value is 25.13 Cr.. The value appears strong and on an upward trend. It has increased from 22.65 Cr. (Sep 2025) to 25.13 Cr., marking an increase of 2.48 Cr..
- For OPM %, as of Dec 2025, the value is 5.12%. The value appears strong and on an upward trend. It has increased from 4.94% (Sep 2025) to 5.12%, marking an increase of 0.18%.
- For Other Income, as of Dec 2025, the value is -0.42 Cr.. The value appears to be declining and may need further review. It has decreased from 2.69 Cr. (Sep 2025) to -0.42 Cr., marking a decrease of 3.11 Cr..
- For Interest, as of Dec 2025, the value is 2.23 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.99 Cr. (Sep 2025) to 2.23 Cr., marking a decrease of 0.76 Cr..
- For Depreciation, as of Dec 2025, the value is 9.02 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 9.06 Cr. (Sep 2025) to 9.02 Cr., marking a decrease of 0.04 Cr..
- For Profit before tax, as of Dec 2025, the value is 13.46 Cr.. The value appears strong and on an upward trend. It has increased from 13.29 Cr. (Sep 2025) to 13.46 Cr., marking an increase of 0.17 Cr..
- For Tax %, as of Dec 2025, the value is 26.37%. The value appears to be increasing, which may not be favorable. It has increased from 25.51% (Sep 2025) to 26.37%, marking an increase of 0.86%.
- For Net Profit, as of Dec 2025, the value is 9.90 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 9.90 Cr..
- For EPS in Rs, as of Dec 2025, the value is 1.58. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 1.58.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: February 27, 2026, 1:35 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 560 | 693 | 700 | 840 | 970 | 904 | 589 | 548 | 818 | 1,051 | 1,067 | 1,289 | 1,770 |
| Expenses | 531 | 661 | 670 | 803 | 905 | 853 | 553 | 521 | 785 | 1,005 | 1,006 | 1,213 | 1,677 |
| Operating Profit | 29 | 32 | 30 | 37 | 65 | 50 | 36 | 27 | 32 | 46 | 61 | 75 | 92 |
| OPM % | 5% | 5% | 4% | 4% | 7% | 6% | 6% | 5% | 4% | 4% | 6% | 6% | 5% |
| Other Income | 0 | 2 | 2 | 1 | 1 | 5 | 2 | 2 | 5 | 4 | 5 | 4 | 5 |
| Interest | 6 | 6 | 5 | 4 | 3 | 3 | 3 | 4 | 4 | 4 | 8 | 9 | 10 |
| Depreciation | 14 | 16 | 17 | 17 | 19 | 21 | 22 | 18 | 18 | 17 | 24 | 26 | 33 |
| Profit before tax | 9 | 11 | 10 | 17 | 44 | 31 | 12 | 7 | 16 | 30 | 34 | 44 | 54 |
| Tax % | 26% | 29% | 27% | 28% | 35% | 31% | -2% | 28% | 25% | 27% | 25% | 26% | |
| Net Profit | 7 | 8 | 7 | 12 | 28 | 21 | 13 | 5 | 12 | 22 | 25 | 33 | 40 |
| EPS in Rs | 1.07 | 1.29 | 1.15 | 1.94 | 4.49 | 3.41 | 1.99 | 0.77 | 1.90 | 3.43 | 3.99 | 5.21 | 6.43 |
| Dividend Payout % | 37% | 35% | 39% | 23% | 11% | 15% | 13% | 33% | 21% | 20% | 20% | 21% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 14.29% | -12.50% | 71.43% | 133.33% | -25.00% | -38.10% | -61.54% | 140.00% | 83.33% | 13.64% | 32.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -26.79% | 83.93% | 61.90% | -158.33% | -13.10% | -23.44% | 201.54% | -56.67% | -69.70% | 18.36% |
Bharat Seats Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 17% |
| 3 Years: | 16% |
| TTM: | 27% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 21% |
| 3 Years: | 40% |
| TTM: | 31% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 37% |
| 3 Years: | 60% |
| 1 Year: | 46% |
| Return on Equity | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 13% |
| 3 Years: | 17% |
| Last Year: | 18% |
Last Updated: September 5, 2025, 2:41 pm
Balance Sheet
Last Updated: December 4, 2025, 2:31 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 13 | 13 |
| Reserves | 35 | 40 | 47 | 56 | 80 | 98 | 107 | 110 | 121 | 140 | 161 | 182 | 194 |
| Borrowings | 102 | 91 | 75 | 63 | 25 | 29 | 40 | 35 | 39 | 66 | 160 | 152 | 132 |
| Other Liabilities | 109 | 127 | 122 | 140 | 172 | 140 | 89 | 140 | 171 | 146 | 179 | 301 | 354 |
| Total Liabilities | 253 | 265 | 250 | 265 | 285 | 273 | 242 | 291 | 337 | 358 | 505 | 648 | 693 |
| Fixed Assets | 150 | 150 | 144 | 146 | 136 | 152 | 150 | 126 | 147 | 199 | 276 | 283 | 367 |
| CWIP | 4 | 3 | 1 | 0 | 13 | 0 | 22 | 30 | 8 | 12 | 49 | 90 | 6 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 99 | 111 | 104 | 119 | 135 | 121 | 69 | 135 | 182 | 147 | 181 | 275 | 320 |
| Total Assets | 253 | 265 | 250 | 265 | 285 | 273 | 242 | 291 | 337 | 358 | 505 | 648 | 693 |
Below is a detailed analysis of the balance sheet data for Bharat Seats Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.00 Cr..
- For Reserves, as of Sep 2025, the value is 194.00 Cr.. The value appears strong and on an upward trend. It has increased from 182.00 Cr. (Mar 2025) to 194.00 Cr., marking an increase of 12.00 Cr..
- For Borrowings, as of Sep 2025, the value is 132.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 152.00 Cr. (Mar 2025) to 132.00 Cr., marking a decrease of 20.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 354.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 301.00 Cr. (Mar 2025) to 354.00 Cr., marking an increase of 53.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 693.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 648.00 Cr. (Mar 2025) to 693.00 Cr., marking an increase of 45.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 367.00 Cr.. The value appears strong and on an upward trend. It has increased from 283.00 Cr. (Mar 2025) to 367.00 Cr., marking an increase of 84.00 Cr..
- For CWIP, as of Sep 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 90.00 Cr. (Mar 2025) to 6.00 Cr., marking a decrease of 84.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 320.00 Cr.. The value appears strong and on an upward trend. It has increased from 275.00 Cr. (Mar 2025) to 320.00 Cr., marking an increase of 45.00 Cr..
- For Total Assets, as of Sep 2025, the value is 693.00 Cr.. The value appears strong and on an upward trend. It has increased from 648.00 Cr. (Mar 2025) to 693.00 Cr., marking an increase of 45.00 Cr..
Notably, the Reserves (194.00 Cr.) exceed the Borrowings (132.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -73.00 | -59.00 | -45.00 | -26.00 | 40.00 | 21.00 | -4.00 | -8.00 | -7.00 | -20.00 | -99.00 | -77.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 43 | 40 | 43 | 41 | 35 | 31 | 22 | 55 | 49 | 34 | 35 | 56 |
| Inventory Days | 8 | 7 | 9 | 8 | 12 | 11 | 16 | 24 | 28 | 12 | 16 | 19 |
| Days Payable | 59 | 56 | 60 | 61 | 66 | 59 | 57 | 99 | 68 | 48 | 59 | 87 |
| Cash Conversion Cycle | -8 | -8 | -8 | -13 | -19 | -17 | -19 | -20 | 9 | -3 | -7 | -13 |
| Working Capital Days | -38 | -35 | -34 | -26 | -13 | -12 | -18 | -13 | 2 | -13 | -17 | -20 |
| ROCE % | 11% | 13% | 12% | 17% | 40% | 28% | 11% | 7% | 12% | 18% | 15% | 16% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 5.21 | 7.98 | 6.86 | 3.79 | 1.53 |
| Diluted EPS (Rs.) | 5.21 | 7.98 | 6.86 | 3.79 | 1.53 |
| Cash EPS (Rs.) | 9.39 | 15.62 | 12.30 | 9.40 | 7.26 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 30.98 | 53.13 | 46.60 | 40.49 | 37.14 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 30.98 | 53.13 | 46.60 | 40.49 | 37.14 |
| Dividend / Share (Rs.) | 1.10 | 1.60 | 1.40 | 0.80 | 0.50 |
| Revenue From Operations / Share (Rs.) | 205.23 | 339.75 | 334.73 | 260.39 | 174.41 |
| PBDIT / Share (Rs.) | 12.59 | 20.80 | 16.03 | 11.92 | 9.20 |
| PBIT / Share (Rs.) | 8.41 | 13.16 | 10.59 | 6.31 | 3.48 |
| PBT / Share (Rs.) | 6.99 | 10.69 | 9.44 | 5.07 | 2.12 |
| Net Profit / Share (Rs.) | 5.21 | 7.98 | 6.86 | 3.79 | 1.53 |
| PBDIT Margin (%) | 6.13 | 6.12 | 4.78 | 4.57 | 5.27 |
| PBIT Margin (%) | 4.09 | 3.87 | 3.16 | 2.42 | 1.99 |
| PBT Margin (%) | 3.40 | 3.14 | 2.81 | 1.94 | 1.21 |
| Net Profit Margin (%) | 2.53 | 2.34 | 2.05 | 1.45 | 0.87 |
| Return on Networth / Equity (%) | 16.80 | 15.01 | 14.72 | 9.37 | 4.12 |
| Return on Capital Employeed (%) | 16.54 | 14.13 | 17.42 | 11.75 | 7.26 |
| Return On Assets (%) | 5.04 | 4.95 | 6.02 | 3.53 | 1.64 |
| Long Term Debt / Equity (X) | 0.25 | 0.31 | 0.22 | 0.25 | 0.21 |
| Total Debt / Equity (X) | 0.41 | 0.52 | 0.40 | 0.29 | 0.25 |
| Asset Turnover Ratio (%) | 2.24 | 2.47 | 3.02 | 2.60 | 2.05 |
| Current Ratio (X) | 0.79 | 0.76 | 0.78 | 1.03 | 0.86 |
| Quick Ratio (X) | 0.63 | 0.57 | 0.61 | 0.71 | 0.65 |
| Inventory Turnover Ratio (X) | 27.08 | 31.12 | 22.01 | 16.85 | 17.83 |
| Dividend Payout Ratio (NP) (%) | 15.36 | 17.54 | 11.65 | 13.17 | 32.66 |
| Dividend Payout Ratio (CP) (%) | 8.52 | 8.96 | 6.50 | 5.31 | 6.88 |
| Earning Retention Ratio (%) | 84.64 | 82.46 | 88.35 | 86.83 | 67.34 |
| Cash Earning Retention Ratio (%) | 91.48 | 91.04 | 93.50 | 94.69 | 93.12 |
| Interest Coverage Ratio (X) | 8.87 | 8.44 | 13.85 | 9.59 | 6.76 |
| Interest Coverage Ratio (Post Tax) (X) | 4.67 | 4.24 | 6.93 | 4.05 | 2.12 |
| Enterprise Value (Cr.) | 559.24 | 538.61 | 313.58 | 245.72 | 222.69 |
| EV / Net Operating Revenue (X) | 0.43 | 0.50 | 0.29 | 0.30 | 0.40 |
| EV / EBITDA (X) | 7.08 | 8.24 | 6.23 | 6.56 | 7.71 |
| MarketCap / Net Operating Revenue (X) | 0.37 | 0.42 | 0.24 | 0.25 | 0.35 |
| Retention Ratios (%) | 84.63 | 82.45 | 88.34 | 86.82 | 67.33 |
| Price / BV (X) | 2.48 | 2.70 | 1.74 | 1.65 | 1.67 |
| Price / Net Operating Revenue (X) | 0.37 | 0.42 | 0.24 | 0.25 | 0.35 |
| EarningsYield | 0.06 | 0.05 | 0.08 | 0.05 | 0.02 |
After reviewing the key financial ratios for Bharat Seats Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 5.21. This value is within the healthy range. It has decreased from 7.98 (Mar 24) to 5.21, marking a decrease of 2.77.
- For Diluted EPS (Rs.), as of Mar 25, the value is 5.21. This value is within the healthy range. It has decreased from 7.98 (Mar 24) to 5.21, marking a decrease of 2.77.
- For Cash EPS (Rs.), as of Mar 25, the value is 9.39. This value is within the healthy range. It has decreased from 15.62 (Mar 24) to 9.39, marking a decrease of 6.23.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 30.98. It has decreased from 53.13 (Mar 24) to 30.98, marking a decrease of 22.15.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 30.98. It has decreased from 53.13 (Mar 24) to 30.98, marking a decrease of 22.15.
- For Dividend / Share (Rs.), as of Mar 25, the value is 1.10. This value is within the healthy range. It has decreased from 1.60 (Mar 24) to 1.10, marking a decrease of 0.50.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 205.23. It has decreased from 339.75 (Mar 24) to 205.23, marking a decrease of 134.52.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 12.59. This value is within the healthy range. It has decreased from 20.80 (Mar 24) to 12.59, marking a decrease of 8.21.
- For PBIT / Share (Rs.), as of Mar 25, the value is 8.41. This value is within the healthy range. It has decreased from 13.16 (Mar 24) to 8.41, marking a decrease of 4.75.
- For PBT / Share (Rs.), as of Mar 25, the value is 6.99. This value is within the healthy range. It has decreased from 10.69 (Mar 24) to 6.99, marking a decrease of 3.70.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 5.21. This value is within the healthy range. It has decreased from 7.98 (Mar 24) to 5.21, marking a decrease of 2.77.
- For PBDIT Margin (%), as of Mar 25, the value is 6.13. This value is below the healthy minimum of 10. It has increased from 6.12 (Mar 24) to 6.13, marking an increase of 0.01.
- For PBIT Margin (%), as of Mar 25, the value is 4.09. This value is below the healthy minimum of 10. It has increased from 3.87 (Mar 24) to 4.09, marking an increase of 0.22.
- For PBT Margin (%), as of Mar 25, the value is 3.40. This value is below the healthy minimum of 10. It has increased from 3.14 (Mar 24) to 3.40, marking an increase of 0.26.
- For Net Profit Margin (%), as of Mar 25, the value is 2.53. This value is below the healthy minimum of 5. It has increased from 2.34 (Mar 24) to 2.53, marking an increase of 0.19.
- For Return on Networth / Equity (%), as of Mar 25, the value is 16.80. This value is within the healthy range. It has increased from 15.01 (Mar 24) to 16.80, marking an increase of 1.79.
- For Return on Capital Employeed (%), as of Mar 25, the value is 16.54. This value is within the healthy range. It has increased from 14.13 (Mar 24) to 16.54, marking an increase of 2.41.
- For Return On Assets (%), as of Mar 25, the value is 5.04. This value is within the healthy range. It has increased from 4.95 (Mar 24) to 5.04, marking an increase of 0.09.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.25. This value is within the healthy range. It has decreased from 0.31 (Mar 24) to 0.25, marking a decrease of 0.06.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.41. This value is within the healthy range. It has decreased from 0.52 (Mar 24) to 0.41, marking a decrease of 0.11.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 2.24. It has decreased from 2.47 (Mar 24) to 2.24, marking a decrease of 0.23.
- For Current Ratio (X), as of Mar 25, the value is 0.79. This value is below the healthy minimum of 1.5. It has increased from 0.76 (Mar 24) to 0.79, marking an increase of 0.03.
- For Quick Ratio (X), as of Mar 25, the value is 0.63. This value is below the healthy minimum of 1. It has increased from 0.57 (Mar 24) to 0.63, marking an increase of 0.06.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 27.08. This value exceeds the healthy maximum of 8. It has decreased from 31.12 (Mar 24) to 27.08, marking a decrease of 4.04.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 15.36. This value is below the healthy minimum of 20. It has decreased from 17.54 (Mar 24) to 15.36, marking a decrease of 2.18.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 8.52. This value is below the healthy minimum of 20. It has decreased from 8.96 (Mar 24) to 8.52, marking a decrease of 0.44.
- For Earning Retention Ratio (%), as of Mar 25, the value is 84.64. This value exceeds the healthy maximum of 70. It has increased from 82.46 (Mar 24) to 84.64, marking an increase of 2.18.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 91.48. This value exceeds the healthy maximum of 70. It has increased from 91.04 (Mar 24) to 91.48, marking an increase of 0.44.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 8.87. This value is within the healthy range. It has increased from 8.44 (Mar 24) to 8.87, marking an increase of 0.43.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.67. This value is within the healthy range. It has increased from 4.24 (Mar 24) to 4.67, marking an increase of 0.43.
- For Enterprise Value (Cr.), as of Mar 25, the value is 559.24. It has increased from 538.61 (Mar 24) to 559.24, marking an increase of 20.63.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.43. This value is below the healthy minimum of 1. It has decreased from 0.50 (Mar 24) to 0.43, marking a decrease of 0.07.
- For EV / EBITDA (X), as of Mar 25, the value is 7.08. This value is within the healthy range. It has decreased from 8.24 (Mar 24) to 7.08, marking a decrease of 1.16.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has decreased from 0.42 (Mar 24) to 0.37, marking a decrease of 0.05.
- For Retention Ratios (%), as of Mar 25, the value is 84.63. This value exceeds the healthy maximum of 70. It has increased from 82.45 (Mar 24) to 84.63, marking an increase of 2.18.
- For Price / BV (X), as of Mar 25, the value is 2.48. This value is within the healthy range. It has decreased from 2.70 (Mar 24) to 2.48, marking a decrease of 0.22.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has decreased from 0.42 (Mar 24) to 0.37, marking a decrease of 0.05.
- For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 24) to 0.06, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bharat Seats Ltd:
- Net Profit Margin: 2.53%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 16.54% (Industry Average ROCE: 15.11%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 16.8% (Industry Average ROE: 122.81%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.67
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.63
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 27.5 (Industry average Stock P/E: 112.18)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.41
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.53%
About the Company - Qualitative Analysis
Bharat Seats Ltd. is a Public Limited Listed company incorporated on 06/03/1986 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L34300DL1986PLC023540 and registration number is 023540. Currently Company is involved in the business activities of Manufacture of parts and accessories for motor vehicles. Company's Total Operating Revenue is Rs. 1288.82 Cr. and Equity Capital is Rs. 12.56 Cr. for the Year ended 31/03/2025.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Auto Ancl - Others | 1, Nelson Mandela Road, New Delhi Delhi 110070 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Rohit Relan | Chairman & Managing Director |
| Mr. Rajiv Arora | WholeTime Director & CEO |
| Mr. Rishabh Relan | Whole Time Director |
| Mr. Sanjay Bhattacharyya | Independent Director |
| Mr. Sudhir Maheshwari | Independent Director |
| Ms. Nisha Malhotra | Independent Director |
| Ms. Vanita Chhabra | Independent Director |
| Mr. Sarthak Behuria | Independent Director |
| Mr. Raman Venkat Challa | Nominee Director |
| Mr. Makoto Kunieda | Nominee Director |
FAQ
What is the intrinsic value of Bharat Seats Ltd?
Bharat Seats Ltd's intrinsic value (as of 05 March 2026) is ₹167.27 which is 7.59% lower the current market price of ₹181.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,136 Cr. market cap, FY2025-2026 high/low of ₹240/62.5, reserves of ₹194 Cr, and liabilities of ₹693 Cr.
What is the Market Cap of Bharat Seats Ltd?
The Market Cap of Bharat Seats Ltd is 1,136 Cr..
What is the current Stock Price of Bharat Seats Ltd as on 05 March 2026?
The current stock price of Bharat Seats Ltd as on 05 March 2026 is ₹181.
What is the High / Low of Bharat Seats Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Bharat Seats Ltd stocks is ₹240/62.5.
What is the Stock P/E of Bharat Seats Ltd?
The Stock P/E of Bharat Seats Ltd is 27.5.
What is the Book Value of Bharat Seats Ltd?
The Book Value of Bharat Seats Ltd is 32.9.
What is the Dividend Yield of Bharat Seats Ltd?
The Dividend Yield of Bharat Seats Ltd is 0.61 %.
What is the ROCE of Bharat Seats Ltd?
The ROCE of Bharat Seats Ltd is 15.6 %.
What is the ROE of Bharat Seats Ltd?
The ROE of Bharat Seats Ltd is 18.0 %.
What is the Face Value of Bharat Seats Ltd?
The Face Value of Bharat Seats Ltd is 2.00.